Status:
COMPLETED
Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients
Lead Sponsor:
The Cleveland Clinic
Conditions:
Hypogammaglobulinemia
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.
Detailed Description
This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Lung transplant
- Hypogammaglobulinemia
Exclusion
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00137748
Start Date
January 1 2001
End Date
January 1 2006
Last Update
June 10 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195